Evaluates seladelpar 10 mg vs. placebo for alkaline phosphatase normalization at 52 weeks
Patients enroll with alkaline phosphatase levels between 1- and 1.67-times upper limit of normal
Read more at prnewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Evaluates seladelpar 10 mg vs. placebo for alkaline phosphatase normalization at 52 weeks
Patients enroll with alkaline phosphatase levels between 1- and 1.67-times upper limit of normal
Read more at prnewswire.com